Dan Riskin is the CEO of Verantos, a company at the forefront of generating high-accuracy real-world evidence in healthcare. With a background in surgery and biomedical informatics, Riskin has led Verantos to become a market leader in integrating diverse data sources for regulatory and reimbursement purposes. His expertise in healthcare artificial intelligence and his entrepreneurial spirit have significantly influenced the industry, benefiting millions of patients annually.
Who is the CEO of Verantos?
With a rich background in both medicine and business, Dan Riskin stands out as a prominent figure in healthcare innovation. He holds an MD from Boston University and an MBA from MIT, specializing in bioinformatics. His medical training includes a surgery residency at UCLA and a fellowship at Stanford University, where he also serves as a Clinical Professor. Riskin's entrepreneurial journey began with the founding of Health Fidelity, followed by Verantos, a company dedicated to generating high-validity real-world evidence using AI.
His expertise in healthcare artificial intelligence has led to products that benefit millions of patients annually, and his policy contributions include serving on the Obama and Biden Healthcare Policy Committees and testifying before Congress.
Work History
Dan Riskin's work history is as impressive as his educational background. Here are the places he has worked previously:
- Verantos - CEO (2012 to Present)
- Health Fidelity - Founder (2009 to 2012)
- Stanford University - Clinical Professor (2008 to Present)
- UCLA - Surgery Resident (2005 to 2007)
Education History
Dan Riskin's educational journey is marked by a blend of medical and business expertise. He earned his MD from Boston University, where he laid the foundation for his medical career. Following this, he pursued a surgery residency at UCLA, honing his skills in a clinical setting. To further specialize, Riskin completed a fellowship at Stanford University, where he also contributes as a Clinical Professor. Complementing his medical training, he obtained an MBA from MIT, focusing on bioinformatics, which has been instrumental in his entrepreneurial ventures and leadership roles in healthcare innovation.
When did Dan Riskin join Verantos?
Dan Riskin founded Verantos in 2015, marking the beginning of his journey with the company. As the founder, he naturally assumed the role of CEO from the outset. With his extensive background in healthcare and artificial intelligence, Riskin has led Verantos for nearly a decade, driving the company's mission to generate high-validity real-world evidence. His leadership has been instrumental in positioning Verantos as a market leader in the healthcare industry.